COMPANY
Cellanome
The Cellanome R3200 Platform is a fully integrated system that combines instrumentation, consumables, and software for multimodal cellular analysis. Source · checked Oct 15, 2026
Sourced facts
- SEC Form D filings: 4 (query "Cellanome") · efts.sec.gov · checked Oct 15, 2026
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Sr. Research Associate, Assay Development | Foster City, CA | Oct 15, 2026 | Oct 16, 2026 |
| Senior Field Service Engineer | Foster City, CA | Sep 29, 2026 | Oct 14, 2026 |
| Staff Systems Integration Engineer | San Diego, CA | Sep 23, 2026 | Oct 14, 2026 |
| Cell Culture Technician | Foster City, CA | Sep 14, 2026 | Oct 14, 2026 |
| Senior Staff Manufacturing Process Engineer | Foster City, CA | Sep 9, 2026 | Oct 14, 2026 |
Open jobs 10
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Sr. Research Associate, Assay Development | Foster City, CA | Oct 15, 2026 | Oct 16, 2026 | Not stated |
| Senior Field Service Engineer | Foster City, CA | Sep 29, 2026 | Oct 14, 2026 | Senior |
| Staff Systems Integration Engineer | San Diego, CA | Sep 23, 2026 | Oct 14, 2026 | Senior |
| Cell Culture Technician | Foster City, CA | Sep 14, 2026 | Oct 14, 2026 | Mid |
| Senior Staff Manufacturing Process Engineer | Foster City, CA | Sep 9, 2026 | Oct 14, 2026 | Senior |
| Head of Systems Engineering | San Diego, CA | Sep 5, 2026 | Oct 14, 2026 | Executive |
| Staff Scientist, Chemistry | Foster City, CA | Aug 14, 2026 | Oct 14, 2026 | Senior |
| Senior Director, Artificial Intelligence | Foster City, CA | Jul 23, 2026 | Oct 14, 2026 | Senior |
| Director, Segment Marketing & Market Development | Foster City, CA or San Diego, CA | Jun 19, 2026 | Oct 14, 2026 | Senior |
| Don't see a perfect role listed for you? We'd love to hear from you! | Foster City, CA | Dec 23, 2022 | Oct 14, 2026 | Mid |
Funding and NIH signals
- SEC Form D raise Raised $75.93M (Form D filed Jun 22, 2026); since then posted 11 roles. SEC Form D 0000905148-26-003005 (Jun 22, 2026)
Evidence (1 event)
- Jun 22, 2026 · SEC Form D 0000905148-26-003005
Name of Issuer: Cellanome, Inc.; CIK: 1886462; Address: Foster City, CA; Submission type: D; Filing date: 2026-06-22; Industry Group: Biotechnology; Date of First Sale: 2025-12-23; Types of Securities Offered: Equity, Other (Series C Preferred Stock); Business combination transaction: false; Total Offering Amount: 75930476; Total Amount Sold: 75930476; Federal exemptions: 06b
- Jun 22, 2026 · SEC Form D 0000905148-26-003005
Connect
See your connections at Cellanome on LinkedIn (search by name, results not checked)